GSK beats quarterly profit estimates on strength in respiratory, general medicines
Published on April 29, 2026.
British pharmaceutical company, GlaxoSmithKline, has reported a first-quarter profit above analysts' expectations, largely due to strong sales of its respiratory and general medicines. The company reported core earnings per capita of 46.5 pence for the three months ended March 31, compared to analyst expectations of 43.3 pence.
Related Articles
Swedish private equity firm EQT sweetens Intertek bid to $12 billion
E.S.M.O.G.A.O., known as "Ethic" is the name of the day:.
Luxury retailer cuts 16% corporate jobs as bankruptcy exit nears
Saks Global is cutting 16% of its corporate workforce as it nears a Chapter 11 bankruptcy exit, aiming for profitability by 2030.
Alaska’s embattled economic development agency approves $700,000 PR budget
Alaskan's economic development agency, AIDEA, approved a new $700,000 communications budget to enhance transparency and promote its mission amid criticism and controversies.